Lénaïg Tanneau
Model-Informed Drug Development Consultant at Pharmetheus- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
La Rochelle, Nouvelle-Aquitaine, France, FR
Languages
-
English Professional working proficiency
-
Spanish Limited working proficiency
-
French Native or bilingual proficiency
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Pharmetheus
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Model-Informed Drug Development Consultant
-
Jul 2023 - Present
-
-
Model-Informed Drug Development Associate Consultant
-
Jun 2022 - Jun 2023
-
-
-
Uppsala University
-
Sweden
-
Higher Education
-
700 & Above Employee
-
PhD student in Pharmacometrics
-
Sep 2016 - May 2022
-
-
Contract Researcher
-
Mar 2018 - Oct 2018
-
-
-
Pharmetheus
-
Sweden
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
MIDD consultant
-
Oct 2019 - Jun 2020
-
-
-
University of Cape Town
-
South Africa
-
Higher Education
-
700 & Above Employee
-
Visiting PHD Student
-
Jan 2019 - Apr 2019
-
-
-
Ipsen
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Clinical pharmacometrician
-
2015 - 2015
-
-
-
Pierre Fabre Group
-
France
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Pharmacokineticist
-
Feb 2014 - Aug 2014
-
-
-
-
Non-resident pharmacy student
-
Sep 2012 - Aug 2013
-
-
-
-
Biologist assistant – Clinical pharmacokinetic study
-
Mar 2013 - May 2013
-
-
-
Pharmacy
-
Région de Bordeaux
-
Pharmacy Assistant
-
2009 - 2012
-
-
Education
-
Uppsala University
Doctor of Philosophy - PhD -
Université Paris Descartes
Master's degree -
Université de Nantes
Doctor of Pharmacy (Pharm.D.) -
University College Cork
-
Université Victor Segalen (Bordeaux II)
-
Lycée François Magendie
Baccalauréat
Community
You need to have a working account to view this content.
Click here to join now